Related Experiment Videos

Atrial natriuretic factor stimulates phosphorylation of a 52-kDa calmodulin-binding protein in vascular smooth muscle

S Nakajo1, T Inagami

  • 1Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232.

Insights

Atrial natriuretic factor (ANF) stimulates the phosphorylation of a 52-kDa protein in vascular smooth muscle cells, suggesting its role in regulating vascular tone. This phosphorylation is influenced by cyclic GMP levels.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Physiology

Background:

  • Vascular smooth muscle tone is crucial for regulating blood pressure.
  • Calmodulin-binding proteins play significant roles in cellular signaling pathways.
  • Atrial natriuretic factor (ANF) is a hormone involved in cardiovascular regulation.

Purpose of the Study:

  • To investigate the effect of ANF on calmodulin-binding protein phosphorylation in vascular smooth muscle cells.
  • To identify specific proteins whose phosphorylation is modulated by ANF.
  • To elucidate the signaling pathways involved in ANF-mediated effects.

Main Methods:

  • Vascular smooth muscle cells were treated with ANF.
  • Phosphorylated calmodulin-binding proteins were detected using molecular weight analysis.
  • The role of cyclic GMP (cGMP) and cyclic AMP (cAMP) was assessed using analogs.
  • The effect of endothelin on phosphorylation was examined.

Main Results:

  • ANF stimulated the phosphorylation of several calmodulin-binding proteins, notably a 52-kDa protein in the cytosolic fraction.
  • This ANF-induced phosphorylation was time- and dose-dependent.
  • The effect was mimicked by 8-bromo-cyclic GMP, but not 8-bromo-cyclic AMP.
  • Endothelin inhibited the phosphorylation of the 52-kDa protein.

Conclusions:

  • The phosphorylation of the 52-kDa protein by ANF, likely mediated by cGMP, is a key event in vascular smooth muscle.
  • This signaling pathway may be critical for the regulation of vascular smooth muscle tone.
  • Further research into this 52-kDa protein could reveal new therapeutic targets for cardiovascular diseases.

Related Concept Videos